IOVS Blood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K. A.
Right arrow Articles by Coster, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K. A.
Right arrow Articles by Coster, D. J.

Investigative Ophthalmology & Visual Science, Vol 26, 23-30, Copyright © 1985 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Penetrating corneal transplantation in the inbred rat: a new model

KA Williams and DJ Coster

A model of orthotopic penetrating keratoplasty has been developed in the inbred rat using both avascular and prevascularized recipient beds. The surgical procedure is conventional and can be achieved with standard instrumentation. Isografts into avascular recipient beds (Fisher 344 into Fisher 344 strain combination) were successful and survived indefinitely with excellent corneal function judged either visually by clarity and lack of oedema, or histologically at autopsy. Allografts into avascular beds (DA into Fisher 344 strain combination) became cloudy and oedematous at a median of day 12 postgraft; 43% spontaneously recovered clarity while the remaining 57% remained opaque or became scarred. Penetrating grafts also were performed in eyes prevascularized by the placement of sutures approximately 3 weeks prior to transplantation. Most isografts into prevascularized and inflamed beds underwent a transient episode of oedema, which quickly resolved and was felt to result from postsurgical inflammation. All allografts into prevascularized beds became oedematous and cloudy; 76% went on to fail completely, while 24% cleared without treatment. End-point histology showed normal graft morphology in the isografts; failed allografts showed a picture consistent with immunologic rejection. The model, which allows corneal transplantation to be performed against a constant histocompatibility barrier, may be useful in studies of rejection.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Hori, M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
J. Immunol., November 1, 2006; 177(9): 5928 - 5935.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. F. Jessup, H. M. Brereton, P. J. Sykes, M. A. Thiel, D. J. Coster, and K. A. Williams
Local Gene Transfer to Modulate Rat Corneal Allograft Rejection
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1675 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
K A Williams, S D Standfield, J R Smith, and D J Coster
Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells
Br. J. Ophthalmol., May 1, 2005; 89(5): 632 - 638.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
Y Jie, Z Pan, Y Chen, Y Wei, W Zhang, Y Wu, H Peng, and L Xu
Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats
Br. J. Ophthalmol., March 1, 2005; 89(3): 364 - 368.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Hori and J. W. Streilein
Survival in High-Risk Eyes of Epithelium-Deprived Orthotopic Corneal Allografts Reconstituted In Vitro with Syngeneic Epithelium
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 658 - 664.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
I. Claerhout
Corneal opacification following keratoplasty in the rat model
Br. J. Ophthalmol., February 1, 2003; 87(2): 249 - 250.
[Full Text]


Home page
IOVSHome page
R. M. Comer, W. J. King, N. Ardjomand, S. Theoharis, A. J. T. George, and D. F. P. Larkin
Effect of Administration of CTLA4-Ig as Protein or cDNA on Corneal Allograft Survival
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1095 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J Plskova, L Kuffova, V Holan, M Filipec, and J V Forrester
Evaluation of corneal graft rejection in a mouse model
Br. J. Ophthalmol., January 1, 2002; 86(1): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Hori and J. W. Streilein
Dynamics of Donor Cell Persistence and Recipient Cell Replacement in Orthotopic Corneal Allografts in Mice
Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1820 - 1828.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Hegde and J. Y. Niederkorn
The Role of Cytotoxic T Lymphocytes in Corneal Allograft Rejection
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3341 - 3347.
[Abstract] [Full Text]


Home page
IOVSHome page
J. Hori, N. Joyce, and J. W. Streilein
Epithelium-Deficient Corneal Allografts Display Immune Privilege beneath the Kidney Capsule
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 443 - 452.
[Abstract] [Full Text]


Home page
IOVSHome page
P. F. Torres, T. P. A. M. Slegers, R. Peek, N. van Rooijen, R. van der Gaag, A. Kijlstra, and A. F. de Vos
Changes in Cytokine mRNA Levels in Experimental Corneal Allografts after Local Clodronate-Liposome Treatment
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3194 - 3201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Association for Research in Vision and Ophthalmology